dc.contributor.author |
Hadjivassiliou, M |
en |
dc.contributor.author |
Stefanaki, C |
en |
dc.contributor.author |
Nicolaidou, E |
en |
dc.contributor.author |
Bethimoutis, G |
en |
dc.contributor.author |
Anyfantakis, V |
en |
dc.contributor.author |
Caroni, C |
en |
dc.contributor.author |
Katsambas, A |
en |
dc.date.accessioned |
2014-03-01T01:26:27Z |
|
dc.date.available |
2014-03-01T01:26:27Z |
|
dc.date.issued |
2007 |
en |
dc.identifier.issn |
0956-4624 |
en |
dc.identifier.uri |
https://dspace.lib.ntua.gr/xmlui/handle/123456789/18077 |
|
dc.subject |
Cervical cancer |
en |
dc.subject |
Genital warts |
en |
dc.subject |
High-risk HPV |
en |
dc.subject |
Human papillomavirus |
en |
dc.subject |
Hybrid capture II assay |
en |
dc.subject |
Low-risk HPV |
en |
dc.subject.classification |
Immunology |
en |
dc.subject.classification |
Infectious Diseases |
en |
dc.subject.other |
adult |
en |
dc.subject.other |
article |
en |
dc.subject.other |
assay |
en |
dc.subject.other |
condyloma acuminatum |
en |
dc.subject.other |
diagnostic test |
en |
dc.subject.other |
human |
en |
dc.subject.other |
major clinical study |
en |
dc.subject.other |
male |
en |
dc.subject.other |
prevalence |
en |
dc.subject.other |
priority journal |
en |
dc.subject.other |
risk factor |
en |
dc.subject.other |
sexual behavior |
en |
dc.subject.other |
sexually transmitted disease |
en |
dc.subject.other |
symptom |
en |
dc.subject.other |
virus detection |
en |
dc.subject.other |
virus infection |
en |
dc.subject.other |
Wart virus |
en |
dc.subject.other |
adolescent |
en |
dc.subject.other |
aged |
en |
dc.subject.other |
Alphapapillomavirus |
en |
dc.subject.other |
anal canal |
en |
dc.subject.other |
classification |
en |
dc.subject.other |
isolation and purification |
en |
dc.subject.other |
middle aged |
en |
dc.subject.other |
pathogenicity |
en |
dc.subject.other |
perineum |
en |
dc.subject.other |
polymerase chain reaction |
en |
dc.subject.other |
RNA probe |
en |
dc.subject.other |
sensitivity and specificity |
en |
dc.subject.other |
sexuality |
en |
dc.subject.other |
urethra |
en |
dc.subject.other |
virology |
en |
dc.subject.other |
diagnostic agent |
en |
dc.subject.other |
Adolescent |
en |
dc.subject.other |
Adult |
en |
dc.subject.other |
Aged |
en |
dc.subject.other |
Alphapapillomavirus |
en |
dc.subject.other |
Anal Canal |
en |
dc.subject.other |
Condylomata Acuminata |
en |
dc.subject.other |
Humans |
en |
dc.subject.other |
Male |
en |
dc.subject.other |
Middle Aged |
en |
dc.subject.other |
Perineum |
en |
dc.subject.other |
Polymerase Chain Reaction |
en |
dc.subject.other |
Risk Factors |
en |
dc.subject.other |
RNA Probes |
en |
dc.subject.other |
Sensitivity and Specificity |
en |
dc.subject.other |
Sexual Partners |
en |
dc.subject.other |
Urethra |
en |
dc.title |
Human papillomavirus assay in genital warts - Correlation with symptoms |
en |
heal.type |
journalArticle |
en |
heal.identifier.primary |
10.1258/095646207780749574 |
en |
heal.identifier.secondary |
http://dx.doi.org/10.1258/095646207780749574 |
en |
heal.language |
English |
en |
heal.publicationDate |
2007 |
en |
heal.abstract |
Our purpose was to investigate the human papillomavirus (HPV) type distribution using the Hybrid Capture 2 (HC2) Microplate assay in males. We tested a urethral swab from 550 HIV-negative males with genital warts and 64 HIV-negative males clinically free of genital warts, partners of HPV-infected females, using the HC2 Microplate assay. A perianal swab was also obtained from patients with perianal warts. In the first group, HPV DNA of any type was detected in 280 (50.9%) patients. Relatively few patients with urethral or perianal warts demonstrated a negative test (both P < 0.0001). Low-risk types were commoner, accounting for 60.0% of the HPV cases, high/intermediate-risk types accounted for 23.6%, while 46 men (116.4%) were infected with both types. Of 13 subjects (20.3%) of the second group who tested positive for HPV DNA, 61.5% were infected by low-risk types, 23.1% by high/intermediate-risk types and 15.4% had a dual infection. In conclusion, male partners of infected females and males with genital warts are predominantly infected by low-risk HPV types, but a substantial proportion is also or only affected by high-risk types. |
en |
heal.publisher |
ROYAL SOC MEDICINE PRESS LTD |
en |
heal.journalName |
International Journal of STD and AIDS |
en |
dc.identifier.doi |
10.1258/095646207780749574 |
en |
dc.identifier.isi |
ISI:000246907400010 |
en |
dc.identifier.volume |
18 |
en |
dc.identifier.issue |
5 |
en |
dc.identifier.spage |
329 |
en |
dc.identifier.epage |
334 |
en |